The Medipattern Corporation
TSX VENTURE : MKI

The Medipattern Corporation

October 20, 2008 06:30 ET

Medipattern's Cindy Rapp Receives "Pioneer Award"

SDMS honours her many accomplishments

TORONTO, ONTARIO--(Marketwire - Oct. 20, 2008) -

Attention: Business/Financial Editors:

The Medipattern Corporation (TSX VENTURE:MKI), a pioneer in the development of medical software solutions that help improve imaging workflow and productivity, is pleased to announce that the Society of Diagnostic Medical Sonography (SDMS) has recognized Cindy Rapp, Medipattern's Vice President of Clinical Program Development, as the 2008 recipient of the Joan P. Baker Pioneer Award. The SDMS Joan P. Baker Pioneer Award was established to honour sonographers who have made outstanding contributions in the profession. The Pioneer Award is awarded to those members who have made focused contributions and have created innovative new directions for sonography.

Ms. Rapp, BS, RDMS, FSDMS, FAIUM, was one of the co-authors of the landmark paper "Solid Breast Nodules: Use of Sonography to Distinguish between Benign and Malignant Lesions" with A. Thomas Stavros (the chairman of Medipattern's advisory board), MD, David Thickman, MD, Mark Dennis, MD, Steve Parker, MD, and Gale Sisney, MD. The paper was published in Radiology in 1995 (196 123-124). This body of work establishes that ultrasound technology can be used effectively to differentiate breast lesions as benign or malignant with a high degree of confidence. Prior to this effort, it was widely believed that the primary role for ultrasound was to establish whether a lesion was solid or cystic or to guide a needle for biopsy. The paper is the basis for the criteria to evaluate breast lesions based upon ultrasound image information. The criteria originally established in the paper, formed the basis for what was to become the American College of Radiology's (ACR) Breast Ultrasound Breast Imaging Report and Data System (BI-RADS®). The ACR officially adopted BI-RADS for breast ultrasound in 2003 and it is the approved methodology for reviewing breast ultrasound imaging today.

Ms. Rapp has been involved in sonography for approximately 25 years. An active member of the Society of Diagnostic Medical Sonography (SDMS) and the American Institute of Ultrasound in Medicine (AIUM), Ms. Rapp received Fellowship into both organizations in 2001. She was also actively involved with the American Registry of Diagnostic Medical Sonographers (ARDMS), where she chaired the task force for the Breast Ultrasound Registry. Ms. Rapp routinely lectures nationally and internationally on various ultrasound topics with an expressed emphasis in breast sonography. She has authored numerous sonographic chapters, articles and award winning scientific exhibits. In 2000, she received the prestigious Kenneth R. Gottesfeld award of excellence for her publication in the JDMS "Ultrasound of Abdominal Wall Hernias". Ms. Rapp received the distinguished sonographer of the year award from the AIUM in 2005.

"Cindy has made significant contributions to the industry. Prior to joining our team to head up the clinical and training programs, Cindy was a valuable member of our Medical Advisory Board and has been an active member of the Medipattern family for the past 6 years. Cindy has played an active role in the development of B-CAD and ensures that we focus on the day to day clinical aspects of the workflow that enables sonographers to be more efficient and communicate effectively through electronic integration of Sonographer worksheets into a dynamic paperless environment," stated Jeff Collins, president and CEO of Medipattern. "All of us at Medipattern are proud to see her many accomplishments acknowledged by the SDMS. Cindy brings an enthusiasm to her work that is infectious and we are pleased that she has joined Medipattern's team to share her experience with all of us and with our customers."



Upcoming Events:

Medipattern will participate in the following events:

- China Medical Exposition
October 20 to 24 Beijing, PRC at the BJEW booth
- Journees Francaises Radiologie
October 24 to 28 Paris, France at the AG Medical Booth
- Radiological Society of North America (RSNA) Annual Meeting
November 30 to December 5 Chicago, IL at the Medipattern Booth and
at the GE Booth


The Medipattern Corporation

Medipattern® is a pioneer in the development of medical software solutions that help improve imaging workflow and productivity. Our first-to-market, award-winning B-CAD® advances breast ultrasound computer aided detection (CAD) by streamlining workflow and organizing information into a comprehensive patient record. Medipattern uses its Cadenza™ CAD Technology to power the digital conversion in medical communications. B-CAD automatically creates fully digital standardized worksheets and reports that make every practice more efficient, productive and ultimately more effective. For more information, please visit the company's website at: www.medipattern.com.

Cadenza™ is a trademark of the Medipattern Corporation. B-CAD® and Medipattern® are registered marks of The Medipattern Corporation. BI-RADS® is a registered trademark of the American College of Radiology.

Forward-looking statements

This document contains forward-looking statements relating to Medipattern's performance, operations, or business environment. These statements are based on what we believe are reasonable assumptions given currently available information and our understanding of Medipattern's current activities. We have tried, whenever possible, to identify these forward-looking statements using words such as "anticipates," "believes," "estimates," "expects," "plans," "intends," "potential," and similar expressions. Forward-looking statements are not guarantees of future performance and involve risks and uncertainties that are difficult to predict or control. A number of factors could cause actual outcomes and results to differ materially from those expressed in forward-looking statements. These factors include but are not limited to those set forth in the Company's corporate filings, (posted at www.sedar.com). In addition, these forward-looking statements relate to the date on which they are made. The Company disclaims any intention or obligation to update or revise any forward-looking statements for any reason. Readers should not rely on forward-looking statements.

The TSX Venture Exchange does not accept responsibility for the adequacy or accuracy of this release and has neither approved nor disapproved of the contents of this release.

Contact Information